In breast cancer patients, depressed serum levels of IL-2, GM-CSF, IFN-γ and enhanced TNF-α and IL-6 amounts were reported in comparison with controls [11] and some of these immune dysfunctions are also present in early-stage tumors. The gene discussed is IL2; the disease is immune system disorder.